截至2025年8月5日收盘，爱尔眼科股价报12.86元，较前一交易日下跌0.02元，跌幅0.16%。当日成交额 达7.20亿元，成交量559755手，振幅1.40%。 爱尔眼科属于医疗服务板块，是国内专业眼科连锁医疗机构。公司主要从事各类眼科疾病诊疗、手术服 务与医学验光配镜等业务。 公司最新公告显示，2025年第二次临时股东大会审议通过了关于部分募投项目结项并将节余募集资金永 久补充流动资金的议案。此外，公司披露截至2025年3月31日股东总数为347329户。 资金流向方面，8月5日主力资金净流出9228.39万元，近五个交易日累计净流出4.19亿元。 风险提示：股市有风险，投资需谨慎。 来源：金融界 ...

Core Viewpoint - Chengdu Puri Eye Hospital Group Co., Ltd. is a leading provider of comprehensive eye care services in China, focusing on innovation and professional expertise to build a competitive advantage in the ophthalmology sector [2]. Group 1: Company Overview - The company specializes in diagnosing, treating, and providing healthcare services for various eye diseases, including refractive surgery, cataracts, and other ophthalmic conditions [2]. - Puri Eye has established a strong brand identity based on "professionalism, innovation, and responsibility," and has created a competitive edge through a nationwide chain of eye hospitals [2]. - The company employs a "full-cycle eye health management" approach, integrating renowned medical experts and cutting-edge technology to enhance service quality [2]. Group 2: Financial Performance - In the first quarter of 2025, the company reported a revenue of 742 million yuan, representing a year-on-year increase of 9.82% [3]. - The net profit for the same period was approximately 27.28 million yuan, showing a significant year-on-year growth of 61.18% [3]. - The gross profit margin stood at 39.34%, indicating a healthy profitability level compared to industry peers [3]. Group 3: Market Position - As of the latest data, Puri Eye's market capitalization is approximately 6.178 billion yuan, with a price-to-earnings (PE) ratio of 67.51 [3]. - The company has a price-to-book (PB) ratio of 2.89, which is competitive within the industry [3]. - The company is positioned favorably against industry averages, with its PE and PB ratios reflecting strong market confidence [3].

Group 1 - The core viewpoint of the article highlights the performance and market position of Aier Eye Hospital Group, noting its recent stock price increase and market capitalization [1] - As of May 6, Aier Eye Hospital's closing price was 13.21 yuan, with a PE ratio of 33.24, marking a 20-day low, and a total market value of 123.21 billion yuan [1] - The company ranks 26th in the medical services industry, which has an average PE ratio of 38.66 and a median of 38.36 [1] Group 2 - Aier Eye Hospital reported a revenue of 6.026 billion yuan for Q1 2025, reflecting a year-on-year increase of 15.97%, and a net profit of 1.05 billion yuan, up 16.71% year-on-year [1] - The gross profit margin for the company stands at 48.02% [1] - As of Q1 2025, 107 institutions hold shares in Aier Eye Hospital, with a total holding of 4.1629 billion shares valued at 55.284 billion yuan [1]